Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

2.

Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.

Cervetto C, Frattaroli D, Maura G, Marcoli M.

Toxicology. 2013 Sep 6;311(1-2):69-77. doi: 10.1016/j.tox.2013.04.004. Epub 2013 Apr 11.

PMID:
23583883
3.

SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models.

Ono Y, Tanaka H, Takata M, Nagahara Y, Noda Y, Tsuruma K, Shimazawa M, Hozumi I, Hara H.

Neurosci Lett. 2014 Jan 24;559:174-8. doi: 10.1016/j.neulet.2013.12.005. Epub 2013 Dec 12.

PMID:
24334165
4.

Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.

Sunyach C, Michaud M, Arnoux T, Bernard-Marissal N, Aebischer J, Latyszenok V, Gouarné C, Raoul C, Pruss RM, Bordet T, Pettmann B.

Neuropharmacology. 2012 Jun;62(7):2346-52. doi: 10.1016/j.neuropharm.2012.02.013. Epub 2012 Feb 20.

PMID:
22369784
5.

Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model.

Luo G, Yi J, Ma C, Xiao Y, Yi F, Yu T, Zhou J.

PLoS One. 2013 Dec 6;8(12):e82112. doi: 10.1371/journal.pone.0082112. eCollection 2013.

6.

Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.

Yoo YE, Ko CP.

Exp Neurol. 2011 Sep;231(1):147-59. doi: 10.1016/j.expneurol.2011.06.003. Epub 2011 Jun 25.

PMID:
21712032
7.

Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.

Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH.

Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16021-6. Epub 2006 Oct 16.

8.

Expression of heat shock transcription factor 1 and its downstream target protein T-cell death associated gene 51 in the spinal cord of a mouse model of amyotrophic lateral sclerosis.

Mimoto T, Morimoto N, Miyazaki K, Kurata T, Sato K, Ikeda Y, Abe K.

Brain Res. 2012 Dec 7;1488:123-31. doi: 10.1016/j.brainres.2012.10.012. Epub 2012 Oct 11.

PMID:
23063459
9.

Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis.

Ringer C, Weihe E, Schütz B.

Neurobiol Dis. 2012 Jan;45(1):547-54. doi: 10.1016/j.nbd.2011.09.011. Epub 2011 Sep 21.

PMID:
21964254
10.

SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy.

Winer L, Srinivasan D, Chun S, Lacomis D, Jaffa M, Fagan A, Holtzman DM, Wancewicz E, Bennett CF, Bowser R, Cudkowicz M, Miller TM.

JAMA Neurol. 2013 Feb;70(2):201-7. doi: 10.1001/jamaneurol.2013.593.

11.

Corrigendum to "Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice".

Gotkine M, Rozenstein L, Einstein O, Abramsky O, Argov Z, Rosenmann H.

Biomed Res Int. 2015;2015:651934. doi: 10.1155/2015/651934. Epub 2015 Feb 3.

12.

Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase.

Campanari ML, García-Ayllón MS, Ciura S, Sáez-Valero J, Kabashi E.

Front Mol Neurosci. 2016 Dec 27;9:160. doi: 10.3389/fnmol.2016.00160. eCollection 2016. Review.

13.

Immunoglobulins from patients with amyotrophic lateral sclerosis affect human erythrocyte acetylcholinesterase.

Sindhuphak R, Karlsson E, Conradi S, Ronnevi LO.

J Neurol Sci. 1988 Sep;86(2-3):195-202.

PMID:
3221239
14.

Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice.

Pohanka M, Pavlis O, Svobodova H, Pikula J.

Interdiscip Toxicol. 2012 Mar;5(1):21-4. doi: 10.2478/v10102-012-0004-7.

15.

ALS: disease or syndrome?

van den Berg LH.

J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):711. doi: 10.1136/jnnp.2011.241513. Epub 2011 Apr 2. No abstract available.

PMID:
21460388

Supplemental Content

Support Center